Bullish option flow detected in Aurinia Pharmaceuticals with 6,382 calls trading, 4x expected, and implied vol increasing over 1 point to 86.88%. Apr-24 18 calls and Feb-24 8 puts are the most active options, with total volume in those strikes near 2,300 contracts. The Put/Call Ratio is 0.32. Earnings are expected on February 27th.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AUPH:
- Aurinia Pharmaceuticals sees FY24 net product revenue $200M-$220M
- Aurinia Pharmaceuticals sees FY23 revenue about $176M, consensus $174.71M
- Aurinia Pharmaceuticals sees Q4 revenue about $45M, consensus $44.2M
- Aurinia Pharmaceuticals submits IND application to FDA for AUR200
- Aurinia Pharmaceuticals put volume heavy and directionally bearish